Search Within

Mark E Robson

Formats
  1. Journal Article (383)
  2. Meeting Abstract (262)
  3. Review (10)
  4. Book Section (7)
  5. Guidelines (7)
  6. Editorial (6)
  7. Miscellaneous (4)
  8. Correspondence (1)
  9. Research Letter (1)
Groups
  1. Breast Medicine Service (681)
  2. Department of Medicine (681)
  3. Population Sciences Research Program (681)
  4. Solid Tumor Oncology Division (681)
  5. Survivorship Research (681)
  6. GSK Faculty (379)

More Groups

People
  1. Kenneth Offit (280)
  2. Zsofia Stadler (116)
  3. Larry Norton (90)
  4. Vijai Joseph (79)
  5. Diana Mandelker (74)
  6. Michael Berger (67)

More People

Years
  1. 2025 (6)
  2. 2024 (33)
  3. 2023 (41)
  4. 2022 (34)
  5. 2021 (46)
  6. 2020 (65)

More Years

Publications
  1. Journal of Clinical Oncology (166)
  2. Cancer Research (50)
  3. Breast Cancer Research and Treatment (33)
  4. JNCI: Journal of the National Cancer Institute (20)
  5. Annals of Oncology (19)
  6. Clinical Cancer Research (17)

More Publications

Publishers
  1. American Society of Clinical Oncology (188)
  2. American Association for Cancer Research (82)
  3. Springer (66)
  4. Nature Publishing Group (60)
  5. Elsevier Inc. (51)
  6. Oxford University Press (43)

More Publishers

Results (681)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of tamoxifen on the risk of metachronous contralateral breast cancer in women with germline mutations of BRCA1 or BRCA2
    Meeting Abstract

    Robson, M. E.; Satagopan, J.; Hudis, C. A.; Boyd, J.; Offit, K.
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save
  • [Commentary on] Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial
    Journal Article

    Robson, M.
    Women's Oncology Review (2002)

    Fulltext@MSK | Save
  • Estrogen receptor-beta expression in hereditary breast cancer - In reply
    Journal Article

    Scheuer, L.; Kauff, N. D.; Robson, M. E.; Offit, K.
    Journal of Clinical Oncology (2002)

    Fulltext@MSK | Save
  • Oophorectomy in carriers of BRCA mutations - Reply
    Journal Article

    Kauff, N. D.; Robson, M. E.; Offit, K.
    New England Journal of Medicine (2002)

    Fulltext@MSK | Save
  • Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers
    Journal Article

    Archey, W. B.; McEachern, K. A.; Robson, M.; Offit, K.; Vaziri, S. A. J.; Casey, G.; Borg, A.; Arrick, B. A.
    Oncogene (2002)

    Fulltext@MSK | Save
  • Unique de novo mutation of BRCA2 in a woman with early onset breast cancer
    Journal Article

    Robson, M.; Scheuer, L.; Nafa, K.; Ellis, N.; Offit, K.
    Journal of Medical Genetics (2002)

    Fulltext@MSK | Save
  • Considerations in genetic counseling for inherited breast cancer predisposition
    Journal Article

    Robson, M. E.; Offit, K.
    Seminars in Radiation Oncology (2002)

    Fulltext@MSK | Save
  • Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer
    Journal Article

    Robson, M. E.
    Cancer Control (2002)

    Fulltext@MSK | Save
  • Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers
    Journal Article

    Scheuer, L.; Kauff, N.; Robson, M.; Kelly, B.; Barakat, R.; Satagopan, J.; Ellis, N.; Hensley, M.; Boyd, J.; Borgen, P.; more...
    Journal of Clinical Oncology (2002)

    Fulltext@MSK | Save
  • Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations
    Journal Article

    Satagopan, J. M.; Boyd, J.; Kauff, N. D.; Robson, M.; Scheuer, L.; Narod, S.; Offit, K.
    Clinical Cancer Research (2002)

    Fulltext@MSK | Save